Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.39 | -23.05 |
PEG Ratio (TTM) | 0.08 | 15.47 |
P/S Ratio (TTM) | 2.33 | 49.46 |
P/B Ratio (TTM) | 0.30 | 18.87 |
P/FCF Ratio (TTM) | -0.41 | -3.27 |
Price to 5YR AVG Earnings Ratio | -0.35 | -3.55 |
Price to 5YR AVG FCF Ratio | -0.46 | -9.37 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -53.28% | -5.14% |
ROE (TTM) | -61.40% | 16.69% |
Net Profit Margin (TTM) | -592.57% | -1,583.93% |
ROIC 5YR AVG | -88.40% | 15.15% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -14.62% | -47.81% | -21.09% |
Revenue | 33.92% | 150.97% | 169.01% |
Net Income | -14.15% | -114.74% | -61.41% |
Cash Flow | -2.45% | -89.02% | -58.40% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.28 | 6.13 |
Quick Ratio (TTM) | 4.28 | 5.85 |
D/E Ratio (TTM) | 0.22 | -15.81 |
Interest Coverage (TTM) | -51.62 | -1.57 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 14.12 |
LTL to 5YR AVG FCF | -0.31 | 0.17 |
Shares Outstanding Growth 5YR AVG | 56.04% | 123.44% |